Get started
Work

Long-Term Survivors With Melanoma Brain Metastases: Clinical Burden and Psychosocial Distress

Year: 2026
Type: article
Abstract: Background: Patients with melanoma brain metastases represent a clinically vulnerable population with a high disease burden. Despite improved survival due to advances in systemic therapies (ST) and radiotherapy (RTX), data on treatment-related adverse events (TRAEs) and psychosocial distress in this group remain limited.
DOI: 10.1016/j.ejcskn.2026.100856
Authors: M. Reitmajer, E. Livingstone, N. Schäffeler, S. Börger, R. Rompel, S. Dugas-Breit, J.C. Hassel, D. Debus, R. Herbst, A. Gesierich, F. Meiss, M.V. Heppt, M. Wanner, E. Dabrowski, C. Gebhardt, K. Drexler, S. Haferkamp, F. Meier, W.K. Peitsch, G. Lodde, L.J. Albrecht, L. Zimmer, A. Forschner
Institutions: Universitätsklinikum Tübingen, Essen University Hospital, University of Kassel, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, Helios Klinikum Erfurt, Universitätsklinikum Würzburg, University of Freiburg, University Medical Center Freiburg, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, Innsbruck Medical University, Universität Innsbruck, Klinikum Ludwigshafen, University Medical Center Hamburg-Eppendorf, University Hospital Regensburg, University Hospital Carl Gustav Carus, Nationales Centrum für Tumorerkrankungen Dresden, Technische Universität Dresden, Klinikum im Friedrichshain
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,340
OpenAlex ID: W7154999974
FWCI:
Cites:
Cited by:
Related to: 10